NCT01224587

Magnetic Marker Monitoring (MMM) Study With Gel Matrix Tablets Under Fasting and Fed Conditions

Characterisation of Gastrointestinal Transit of Four New Developed Gel Matrix Tablets With Different Erosion Rates by Means of MMM Measurement Under Fasting and Fed Conditions

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 5 (actual)
• Sponsor: AstraZeneca · Industry
• Sex: Male
• Age: 18 Years – 55 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to monitor the gastrointestinal transport of eroding gel matrix placebo tablets in healthy male volunteers under fasting and fed conditions. The method which is used is an imaging technique.

Conditions

• Magnetic Marker Monitoring
• Gastrointestinal-transport
• Gastric Emptying Time
• Small Intestinal Transit Time
• Time for Colon Arrival
• Food Effect

Interventions

Type	Name	Description
DRUG	D1000078	Oral, one single dose
DRUG	D1000082	Oral, one single dose
DRUG	D1000083	Oral, one single dose
DRUG	D1000085	Oral, one single dose

Timeline

• Start date: 2010-10-01
• Primary completion: 2010-11-01
• Completion: 2010-11-01
• First posted: 2010-10-20
• Last updated: 2010-11-04

Locations

1 site across 1 country: Germany